Stingray Therapeutics
PrivateLast Round
Grant
Nov 21, 2023
Total Funding Raised
$18.93M
Company Overview
Stingray Therapeutics is a biotechnology company that develops immunotherapies designed to treat various types of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stingray Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Stingray Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 21, 2023 | ||||
| Seed | Jan 23, 2023 | ||||
| Grant | Oct 4, 2022 | ||||
| Pre Seed | Aug 13, 2020 |
Key People
Founding team and executive leadership
Stingray Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| Catalytic Impact Foundation | Seed |
| Cancer Prevention and Research Institute of Texas | Grant |
| Green Park & Golf Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 21, 2023
Secured $14M in grant funding.
- Jan 23, 2023
$3M round completed.
Stingray Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Stingray Therapeutics's valuation, stock price, and market status.
